Indication
Severe pre-eclampsia
Severe pre-eclampsia—clinically classified as pre-eclampsia with severe features—is a life-threatening, multi-system hypertensive disorder that develops in pregnant or postpartum individuals, typically after 20 weeks of gestation. Read more about Severe pre-eclampsia
46 drugs 22 manufacturers
Drugs that treat it
Common Severe pre-eclampsia therapies.
MAGNESIUM SULFATE (magnesium sulfate in sterile water)
MAGNESIUM SULFATE (magnesium sulfate in sterile water)
MAGNESIUM SULFATE (magnesium sulfate in sterile water)
MAGNESIUM SULFATE (magnesium sulfate in sterile water)
MAGNESIUM SULFATE
MAGNESIUM SULFATE
MAGNESIUM SULFATE-D5W (magnesium sulfate/dextrose 5 % in water)
MAGNESIUM SULFATE-D5W (magnesium sulfate/dextrose 5 % in water)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSevere pre-eclampsia—clinically classified as pre-eclampsia with severe features—is a life-threatening, multi-system hypertensive disorder that develops in pregnant or postpartum individuals, typically after 20 weeks of gestation.
Pathophysiologically driven by abnormal placental spiral artery remodeling, systemic endothelial dysfunction, and widespread microvascular hypoperfusion, it primarily compromises the maternal cardiovascular, renal, hepatic, pulmonary, and central nervous systems.
The condition is clinically defined by severe-range hypertension—specifically a systolic blood pressure of 160 mm Hg or higher, or a diastolic blood pressure of 110 mm Hg or higher—and/or evidence of maternal end-organ injury, such as thrombocytopenia, impaired hepatic function, progressive renal insufficiency, pulmonary edema, or persistent neurological symptoms.
- nih.gov
Severe pre-eclampsia—clinically classified as pre-eclampsia with severe features—is a life-threatening, multi-system hypertensive disorder that develops in pregnant or postpartum individuals, typically after 20 weeks of gestation
- obgproject.com
Severe pre-eclampsia—clinically classified as pre-eclampsia with severe features—is a life-threatening, multi-system hypertensive disorder that develops in pregnant or postpartum individuals, typically after 20 weeks of gestation Pathophysiologically driven by abnormal placental spiral artery remodeling, systemic endothelial dysfunction, and widespread microvascular hypoperfusion, it primarily compromises the maternal cardiovascular, renal, hepatic, pulmonary, and central nervous systems The con...
- nih.gov
Severe pre-eclampsia—clinically classified as pre-eclampsia with severe features—is a life-threatening, multi-system hypertensive disorder that develops in pregnant or postpartum individuals, typically after 20 weeks of gestation The condition is clinically defined by severe-range hypertension—specifically a systolic blood pressure of 160 mm Hg or higher, or a diastolic blood pressure of 110 mm Hg or higher—and/or evidence of maternal end-organ injury, such as thrombocytopenia, impaired hepatic ...
- nih.gov
Pathophysiologically driven by abnormal placental spiral artery remodeling, systemic endothelial dysfunction, and widespread microvascular hypoperfusion, it primarily compromises the maternal cardiovascular, renal, hepatic, pulmonary, and central nervous systems
- nih.gov
Pathophysiologically driven by abnormal placental spiral artery remodeling, systemic endothelial dysfunction, and widespread microvascular hypoperfusion, it primarily compromises the maternal cardiovascular, renal, hepatic, pulmonary, and central nervous systems
- nih.gov
The condition is clinically defined by severe-range hypertension—specifically a systolic blood pressure of 160 mm Hg or higher, or a diastolic blood pressure of 110 mm Hg or higher—and/or evidence of maternal end-organ injury, such as thrombocytopenia, impaired hepatic function, progressive renal insufficiency, pulmonary edema, or persistent neurological symptoms
Personalize your experience
Follow Severe pre-eclampsia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.